During the past decade, Medical Corporation Heishinkai OCROM Clinic conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 4 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 3 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Corporation Heishinkai OCROM Clinic" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "AnGes, Inc." with 2 trials sponsored and "Medicago" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Corporation Heishinkai OCROM Clinic" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Japan Agency for Medical Research and Development" with 2 trials as a collaborator and "Mitsubishi Tanabe Pharma Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Medical Corporation Heishinkai OCROM Clinic" are "Diabetes Mellitus, Type 2" (5 trials), "Obesity" (4 trials), "Diabetes Mellitus" (2 trials), "Type 2 Diabetes" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Medical Corporation Heishinkai OCROM Clinic" in a lesser frequency.

Most popular intervention types in "Medical Corporation Heishinkai OCROM Clinic" are "Drug" (15 trials), "Biological" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Tirzepatide" (3 trials), "Dulaglutide" (2 trials), "empagliflozin 25 mg" (2 trials) and "13vPnC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Corporation Heishinkai OCROM Clinic" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Medical Corporation Heishinkai OCROM Clinic". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Medical Corporation Heishinkai OCROM Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Corporation Heishinkai OCROM Clinic, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".